| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |